These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12515993)

  • 21. Adaptation and Initial Psychometric Evaluation of an Informed Prostate Cancer Screening Decision Self-Efficacy Scale for African-American Men.
    Owens OL; Wooten NR; Tavakoli AS
    J Racial Ethn Health Disparities; 2020 Aug; 7(4):746-759. PubMed ID: 31997285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
    Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
    Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why do men refuse or attend population-based screening for prostate cancer?
    Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
    J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary symptoms as a predictor for participation in prostate cancer screening among African American men.
    Weinrich SP; Weinrich M; Mettlin C; Reynolds WA; Wofford JE
    Prostate; 1998 Dec; 37(4):215-22. PubMed ID: 9831217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of prostate screening health beliefs and practices between African American and Caucasian men.
    Lambert S; Fearing A; Bell D; Newton M
    ABNF J; 2002; 13(3):61-3. PubMed ID: 12108142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge, attitudes and beliefs of women about the importance of prostate cancer screening.
    Blanchard K; Proverbs-Singh T; Katner A; Lifsey D; Pollard S; Rayford W
    J Natl Med Assoc; 2005 Oct; 97(10):1378-85. PubMed ID: 16353659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina.
    Conlisk EA; Lengerich EJ; Demark-Wahnefried W; Schildkraut JM; Aldrich TE
    Urology; 1999 Jun; 53(6):1194-9. PubMed ID: 10367851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening in Black men: Screening intention, knowledge, attitudes, and reasons for participation.
    Miller DB; Hamler TC; Qin W
    Soc Work Health Care; 2020 Sep; 59(8):543-556. PubMed ID: 32804046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-efficacy and importance of participation reasons as predictors for prostate cancer screening intention in African American men.
    Qin W; Hamler TC; Miller DB
    Ethn Health; 2022 Feb; 27(2):316-328. PubMed ID: 32046530
    [No Abstract]   [Full Text] [Related]  

  • 30. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
    Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
    Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen in a community screening program.
    Schwartz KL; Kau TY; Severson RK; Demers RY
    J Fam Pract; 1995 Aug; 41(2):163-8. PubMed ID: 7543556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing Hispanic participation in prostate cancer screening.
    Zimmerman SM
    Oncol Nurs Forum; 1997 Apr; 24(3):499-504. PubMed ID: 9127362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Educating African-American men about prostate cancer: impact on awareness and knowledge.
    Wilkinson S; List M; Sinner M; Dai L; Chodak G
    Urology; 2003 Feb; 61(2):308-13. PubMed ID: 12597936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a spiritually based educational intervention to increase informed decision making for prostate cancer screening among church-attending African American men.
    Holt CL; Wynn TA; Southward P; Litaker MS; Jeames S; Schulz E
    J Health Commun; 2009 Sep; 14(6):590-604. PubMed ID: 19731129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.
    Dickey SL; Cormier EM; Whyte J; Graven L; Ralston PA
    Public Health Nurs; 2016 Nov; 33(6):483-492. PubMed ID: 26790837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cues to action in prostate cancer screening.
    McKee JM
    Oncol Nurs Forum; 1994 Aug; 21(7):1171-6. PubMed ID: 7971427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptivity of African-American men to prostate cancer screening.
    Myers RE; Wolf TA; Balshem AM; Ross EA; Chodak GW
    Urology; 1994 Apr; 43(4):480-7. PubMed ID: 8154068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer screening in African American and Caribbean males: detriment in delay.
    Parchment YD
    ABNF J; 2004; 15(6):116-20. PubMed ID: 18399361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
    Spain P; Carpenter WR; Talcott JA; Clark JA; Do YK; Hamilton RJ; Galanko JA; Jackman A; Godley PA
    Cancer; 2008 Oct; 113(8):2180-7. PubMed ID: 18798229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.